Xiaohong Xie

1.5k citations
90 papers · 999 indexed · h-index 19
Topics
Lung Cancer Treatments and Mutations (25 papers)Respiratory viral infections research (19 papers)Cancer Immunotherapy and Biomarkers (19 papers)
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Xiaohong Xie

79 papers receiving 992 citations

Peers

Xiaohong Xie
Comparison fields: 5 of 99
  • Pulmonary and Respiratory Medicine 407
  • Oncology 348
  • Epidemiology 264
  • Molecular Biology 184
  • Immunology 124
Replace Monika Laszkowska with:
Monika Laszkowska United States
Hui Yao China
Sheng‐Hao Lin Taiwan
Qin‐Yan Gao China
Jörgen Kristensen Sweden
Qianwen Li China
Arne Kandulski Germany
Colleen S. Curran United States
Yudong Qiu China
Vajarabhongsa Bhudhisawasdi Thailand
Xiaohong Xie relative to Monika Laszkowska United States Monika Laszkowska's profile →
Citations per field
00.5×1.5×2.1×
Monika Laszkowska · 1×
Citations per year

Countries citing papers authored by Xiaohong Xie

Since Specialization
Citations

This map shows the geographic impact of Xiaohong Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohong Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohong Xie more than expected).

Fields of papers citing papers by Xiaohong Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohong Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohong Xie. The network helps show where Xiaohong Xie may publish in the future.

Co-authorship network of co-authors of Xiaohong Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohong Xie. A scholar is included among the top collaborators of Xiaohong Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohong Xie. Xiaohong Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 0
3 4
4 1
5 29
6 1
7 1
8 1
9 11
10 7
11 11
12 7
13 10
14 3
15 14
16 6
17 8
18 28
19 21
20 23

About Xiaohong Xie

Xiaohong Xie is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 90 papers that have together received 999 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (25 papers), Respiratory viral infections research (19 papers) and Cancer Immunotherapy and Biomarkers (19 papers). The work is most often cited by research in Geriatrics and Gerontology (60 citations), Oncology (348 citations) and Pulmonary and Respiratory Medicine (407 citations). Xiaohong Xie has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Enmei Liu, Chengzhi Zhou, Yinyin Qin, Na Zang, Xinqing Lin, Zhanhong Xie, Ren Luo, Yu Deng, Simin Li and Lijia Wang. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026